On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Johnson & Johnson (United States)

InstitutionResearch output, impact & collaborations

Johnson & Johnson (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Johnson & Johnson (United States)?

ScholarIQrecord summary

Johnson & Johnson (United States) is a research organisation in New Brunswick, US. OpenAlex records 14,651 works and 1,545,386 citations for it. 6,416 researchers list it as their most recent affiliation.

How many works does Johnson & Johnson (United States) have?

ScholarIQindexed works

Johnson & Johnson (United States) has 14,651 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Johnson & Johnson (United States) have?

ScholarIQcitation count

Johnson & Johnson (United States) has 1,545,386 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Johnson & Johnson (United States)?

ScholarIQresearcher count

Johnson & Johnson (United States) has 6,416 researchers in the ScholarIQ index.

What is the average h-index at Johnson & Johnson (United States)?

ScholarIQavg h-index

Johnson & Johnson (United States) has an average h-index of 45.7 in OpenAlex.

What is the ROR of Johnson & Johnson (United States)?

ScholarIQror

The ROR for Johnson & Johnson (United States) is on the source record.

What is the OpenAlex record for Johnson & Johnson (United States)?

ScholarIQopenalex

The OpenAlex for Johnson & Johnson (United States) is on the source record.

Who are the most-cited researchers behind Johnson & Johnson (United States)?

ScholarIQtop researchers by citations
1
Charles G. Drake · Cancer Immunotherapy and Biomarkers
1,156 works91,871 citations
2
Dirk Gevers · Gut microbiota and health
223 works91,485 citations
3
Wayne C. Drevets · Treatment of Major Depression
467 works70,734 citations
4
Jeffrey J. Headd · Enzyme Structure and Function
28 works60,025 citations
5
Dawn Waterworth · Genetic Associations and Epidemiology
263 works52,875 citations

What are the most-cited papers on Johnson & Johnson (United States)?

ScholarIQmost cited works
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, Scott Gettinger, David C. Smith, David F. McDermott, John D. Powderly, Richard D. Carvajal, Jeffrey A. Sosman, Michael B. Atkins, Philip D. Leming, David R. Spigel, Scott Antonia, Leora Horn, Charles G. Drake, Drew M. Pardoll, Lieping Chen, William H. Sharfman, Robert A. Anders, Janis M. Taube, Tracee L. McMiller, Haiying Xu, Alan J. Korman, Maria Jure–Kunkel, Shruti Agrawal, D. G. McDonald, Georgia Kollia, Ashok Gupta, Jon M. Wigginton, Mario Sznol
New England Journal of Medicine. 201212,730 CitationsOPEN ACCESS
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg, Guohua Pan, Daniel E. Singer, Werner Hacke, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Jonathan P. Piccini, Richard C. Becker, Christopher C. Nessel, John F. Paolini, Scott D. Berkowitz, Keith A.A. Fox, Robert M. Califf
New England Journal of Medicine. 20119,441 CitationsOPEN ACCESS
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow, Wen-Jen Hwu, Suzanne L. Topalian, Patrick Hwu, Charles G. Drake, Luis H. Camacho, John Kauh, Kunle Odunsi, Henry C. Pitot, Omid Hamid, Shailender Bhatia, Renato Martins, Keith D. Eaton, Shuming Chen, Theresa M. Salay, Suresh Alaparthy, Joseph F. Grosso, Alan J. Korman, Susan Parker, Shruti Agrawal, S. Goldberg, Drew M. Pardoll, Ashok Gupta, Jon M. Wigginton
New England Journal of Medicine. 20128,040 CitationsOPEN ACCESS
Biological, clinical and population relevance of 95 loci for blood lipids
Tanya M. Teslovich, Kiran Musunuru, Albert V. Smith, Andrew C. Edmondson, Ioannis M. Stylianou, Masahiro Koseki, James P. Pirruccello, Samuli Ripatti, Daniel I. Chasman, Cristen J. Willer, Christopher T. Johansen, Sigrid W. Fouchier, Aaron Isaacs, Gina M. Peloso, Maja Barbalić, Sally L. Ricketts, Joshua C. Bis, Yurii S. Aulchenko, Guðmar Þorleifsson, Mary F. Feitosa, John C. Chambers, Marju Orho‐Melander, Olle Melander, Toby Johnson, Xiaohui Li, Xiuqing Guo, Mingyao Li, Yoon Shin Cho, Min Jin Go, Young Jin Kim, Jong‐Young Lee, Taesung Park, Kyunga Kim, Xueling Sim, Rick Twee‐Hee Ong, Damien C. Croteau‐Chonka, Leslie A. Lange, Joshua D. Smith, Kijoung Song, Jing Hua Zhao, Xin Yuan, Jian’an Luan, Claudia Lamina, Andreas Ziegler, Weihua Zhang, Robert Y.L. Zee, Alan F. Wright, Jacqueline C.M. Witteman, James F. Wilson, Gonneke Willemsen, H.‐Erich Wichmann, John B. Whitfield, Dawn Waterworth, Nicholas J. Wareham, Gérard Waeber, Péter Vollenweider, Benjamin F. Voight, Véronique Vitart, André G. Uitterlinden, Manuela Uda, Jaakko Tuomilehto, John R. Thompson, Toshiko Tanaka, Ida Surakka, Heather M. Stringham, Tim D. Spector, Nicole Soranzo, Johannes H. Smit, Juha Sinisalo, Kaisa Silander, Eric J.G. Sijbrands, Angelo Scuteri, James Scott, David Schlessinger, Serena Sanna, Veikko Salomaa, Juha Saharinen, Chiara Sabatti, Aimo Ruokonen, Igor Rudan, Lynda M. Rose, Robert Roberts, Mark J. Rieder, Bruce M. Psaty, Peter P. Pramstaller, Irene Pichler, Markus Perola, Brenda W.J.H. Penninx, Nancy L. Pedersen, Cristian Pattaro, Alex Parker, Guillaume Paré, Ben A. Oostra, Christopher J. O’Donnell, Markku S. Nieminen, Deborah A. Nickerson, Grant W. Montgomery, Thomas Meitinger, Ruth McPherson, Mark I. McCarthy
Nature. 20103,705 CitationsOPEN ACCESS
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer, Charles G. Drake, Ira Wollner, John D. Powderly, Joel Picus, William H. Sharfman, Elizabeth Stankevich, Alice Pons, Theresa M. Salay, Tracee L. McMiller, Marta M. Gilson, Changyu Wang, Mark Selby, Janis M. Taube, Robert A. Anders, Lieping Chen, Alan J. Korman, Drew M. Pardoll, Israel Lowy, Suzanne L. Topalian
Journal of Clinical Oncology. 20102,952 CitationsOPEN ACCESS

How much of the research on Johnson & Johnson (United States) is open access?

ScholarIQopen access share
83%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
25%
Bronze
42%
Closed
17%

Related on ScholarIQ

470M+ articles · 14-day free trial